No meaningful insider selling signal — the transactions are primarily tax-related and routine. Traders should not interpret this cluster as bearish; monitor for future open-market activity if sustained selling emerges.
Price Chart
Executive Summary
A cluster of insider transactions at Jazz Pharmaceuticals over the past week includes one open-market sale by the Chief Accounting Officer and a director, while the CEO, R&D chief, and other executives surrendered shares to cover tax obligations from equity vesting. The majority of the activity represents non-cash tax withholding events, not discretionary selling.
Key Financial Metrics
Key Facts
- SVP & Chief Accounting Officer Patricia Carr sold $235,444 in shares on open market.
- Director Bruce Cozadd sold $587,843 in shares on open market.
- CEO Renée Galá and other C-suite executives (Iannone, Patil, Carr) surrendered shares for tax withholding totaling $3.7 million — these are non-cash, routine transactions tied to vesting of equity awards.
- Total open-market selling: $823,287 (0.007% of $11.2B market cap), below materiality threshold.
Financial Impact
$823,287 in open-market sales, representing 0.007% of market cap — immaterial in scale
Risk Factors
- Perception risk: Large tax-withholding transactions may be misinterpreted as insider selling pressure.
- Concentration of equity vesting: Suggests a seasonal or scheduled vesting event, which could recur annually.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (6 trades, 7d window) | cluster-JAZZ-1773091287947 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 6d ago | Press Release | $213.76 $211.97 | ▼ −0.84% | ▼ −1.36% | $210.99 (−1.30%) |
Oct 9, 2026 17d ago | 8-K | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 8, 2026 17d ago | 144 | $218.42 $216.75 | ▼ −0.76% | ▼ −0.70% | $210.99 (−3.40%) |
Oct 6, 2026 19d ago | 144 | $231.19 $222.45 | ▼ −3.78% | ▼ −3.36% | $210.99 (−8.74%) |
Oct 1, 2026 24d ago | 144 | $235.67 $236.04 | ▲ +0.16% | ▼ −0.52% | $210.99 (−10.47%) |
Sep 15, 2026 5w ago | 8-K | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 14, 2026 5w ago | Insider Cluster | $240.83 $243.59 | ▲ +1.15% | ▲ +1.59% | $210.99 (−12.39%) |
Sep 10, 2026 6w ago | Insider Cluster | $245.80 $245.87 | ▲ +0.03% | ▲ +0.47% | $210.99 (−14.16%) |
Sep 2, 2026 7w ago | Insider Cluster | $247.57 $246.81 | ▲ +0.30% | ▼ −0.08% | $210.99 (+14.78%) |
Aug 31, 2026 7w ago | 144 | $243.71 $245.57 | ▲ +0.76% | ▲ +0.32% | $210.99 (−13.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers